Mergers & Acquisitions

Garphi provides unmatched expertise throughout the transaction support services life-cycle – from initial target acquisition screening through post-acquisition integration support. We identify the true value of an opportunity by combining our meticulous financial analysis with the industry knowledge required to understand how the shifting market landscape can impact potential deals. Our experts provide the local insight and skills required to orchestrate complex multinational M&A transactions. Through the input of pharmaceutical & biotech industry leaders at Garphi, we provide solutions to the greatest M&A pitfalls and give clear, detailed insight of trends in pharmaceutical deals. The result: a clear roadmap to the M&A landscape leading to successful closure and facilitation of post-merger integration. Our team works with companies of all sizes and capabilities to:

• Build a competitive deal-making process

• Prepare appropriate financial models for targeted assets

• Develop deal structures for acquisition

• Negotiate definitive agreements

• Resolve complex issues

Our global network opens up new possibilities for acquisition, and offers an edge in negotiating multinational, multi-cultural deals. Unlike an investment bank or financial adviser who simply closes the deal, Garphi brings decades of experience in the pharmaceutical industry to each assignment. We work with you to proactively identify potential acquisitions based on your company’s specific objectives and requirements and work with you on integration post the merger.

Want to try us out…write to us at info@garphi.com